Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 8;17(1):18.
doi: 10.1186/s13044-024-00200-z.

Hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis

Dominic Cooper  1 , Rajneesh Kaur, Femi E Ayeni  2   3 , Guy D Eslick  4 , Senarath Edirimanne  5   4
Affiliations
Review

Hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis

Dominic Cooper et al. Thyroid Res. .

Abstract

Background: The incidence of hypothyroidism following hemithyroidectomy and risk factors associated with its occurrence are not completely understood. This systematic review investigated the incidence and risk factors for hypothyroidism, thyroxine supplementation following hemithyroidectomy as well as the course of post-operative hypothyroidism, including the time to hypothyroidism and incidence of transient hypothyroidism.

Methods: Searches were conducted in MEDLINE, EMBASE, Scopus, and Cochrane library for studies reporting the incidence of hypothyroidism or thyroxine supplementation following hemithyroidectomy.

Results: Sixty-six studies were eligible for inclusion: 36 reported risk factors, and 27 reported post-operative course of hypothyroidism. Median follow-up was 25.2 months. The pooled incidence of hypothyroidism was 29% (95% CI, 25-34%; P<0.001). Transient hypothyroidism occurred in 34% of patients (95% CI, 21-47%; P<0.001). The pooled incidence of thyroxine supplementation was 23% (95% CI, 19-27%; P<0.001), overt hypothyroidism 4% (95% CI, 2-6%, P<0.001). Risk factors for development of hypothyroidism included pre-operative thyroid stimulating hormone (TSH) (WMD, 0.87; 95% CI, 0.75-0.98; P<0.001), TSH ≥ 2 mIU/L (RR, 2.87; 95% CI, 2.43-3.40; P<0.001), female sex (RR, 1.19; 95% CI, 1.08-1.32; P=0.007), age (WMD, 2.29; 95% CI, 1.20-3.38; P<0.001), right sided hemithyroidectomy (RR, 1.35; 95% CI, 1.10-1.65, P=0.003), the presence of autoantibodies anti-TPO (RR, 1.92; 95% CI, 1.49-2.48; P<0.001), anti-Tg (RR, 1.53; 95% CI, 1.40-1.88; P<0.001), and Hashimoto's thyroiditis (RR, 2.05; 95% CI, 1.57-2.68; P=0.001).

Conclusion: A significant number of patients will develop hypothyroidism or require thyroxine following hemithyroidectomy. An awareness of patient risk factors and postoperative thyroid function course will assist in counselling patients on their risk profile and guiding management.

Keywords: Hemithyroidectomy; Hypothyroid; Hypothyroidism; Thyroid lobectomy; Thyroxine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
PRISMA diagram illustrating selection of studies
Fig. 2
Fig. 2
Individual and pooled incidence of hypothyroidism following hemithyroidectomy
Fig. 3
Fig. 3
Individual and pooled incidence of thyroxine supplementation following hemithyroidectomy
Fig. 4
Fig. 4
Individual and pooled incidence of overt hypothyroidism following hemithyroidectomy
Fig. 5
Fig. 5
Individual and pooled RR for TSH ≥2 between hypothyroid and euthyroid groups following hemithyroidectomy
Fig. 6
Fig. 6
Individual and pooled WMD for age between hypothyroid and euthyroid groups following hemithyroidectomy
Fig. 7
Fig. 7
Individual and pooled RR for female sex between hypothyroid and euthyroid groups following hemithyroidectomy
Fig. 8
Fig. 8
Individual and pooled RR for Hashimoto’s thyroiditis between hypothyroid and euthyroid groups following hemithyroidectomy
Fig. 9
Fig. 9
Individual and pooled incidence of transient hypothyroidism following hemithyroidectomy
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Fewins J, Simpson CB, Miller FR. Complications of thyroid and parathyroid surgery. Otolaryngol Clin North Am. 2003;36(1):189–206. doi: 10.1016/s0030-6665(02)00129-9. - DOI - PubMed
    1. Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab. 2002;87:4154–4159. doi: 10.1210/jc.2001-011762. - DOI - PubMed
    1. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501–9. doi: 10.1056/NEJM200102153440707. - DOI - PubMed
    1. Turner MR, Camacho X, Fischer HD, et al. Levothyroxine dose and risk of fractures in older adults: nested case-control study. BMJ. 2011;342:d2238. doi: 10.1136/bmj.d2238. - DOI - PMC - PubMed
    1. Noureldine SI, Khan A, Massasati SA, et al. Thyroid hormone replacement therapy, surveillance ultrasonography, and fine-needle aspiration after hemithyroidectomy. Ann Otol Rhinol Laryngol. 2013;122(7):450–456. doi: 10.1177/000348941312200707. - DOI - PubMed

LinkOut - more resources